Division of Hematology-Oncology, Department of Medicine, University of Miami and Sylvester Comprehensive Cancer Center, Miami, FL.
Department of Medicine and Department of Biomedical Data Science, Stanford University, Stanford, CA.
Blood Adv. 2021 Dec 14;5(23):5072-5085. doi: 10.1182/bloodadvances.2021004304.
Human germinal center-associated lymphoma (HGAL) is an adaptor protein specifically expressed in germinal center lymphocytes. High expression of HGAL is a predictor of prolonged survival of diffuse large B-cell lymphoma (DLBCL) and classic Hodgkin lymphoma. Furthermore, HGAL expression is associated with early-stage DLBCL, thus potentially limiting lymphoma dissemination. In our previous studies, we demonstrated that HGAL regulates B-cell receptor signaling and cell motility in vitro and deciphered some molecular mechanisms underlying these effects. By using novel animal models for in vivo DLBCL dispersion, we demonstrate here that HGAL decreases lymphoma dissemination and prolongs survival. Furthermore, by using an unbiased proteomic approach, we demonstrate that HGAL may interact with multiple cytoskeletal proteins thereby implicating a multiplicity of effects in regulating lymphoma motility and spread. Specifically, we show that HGAL interacts with tubulin, and this interaction may also contribute to HGAL effects on cell motility. These findings recapitulate previous observations in humans, establish the role of HGAL in dissemination of lymphoma in vivo, and explain improved survival of patients with HGAL-expressing lymphomas.
人类生发中心相关淋巴瘤(HGAL)是一种特异性表达于生发中心淋巴细胞的衔接蛋白。HGAL 的高表达是弥漫性大 B 细胞淋巴瘤(DLBCL)和经典霍奇金淋巴瘤患者生存时间延长的预测指标。此外,HGAL 的表达与早期 DLBCL 相关,从而可能限制淋巴瘤的扩散。在我们之前的研究中,我们证明了 HGAL 在体外调节 B 细胞受体信号和细胞迁移,并阐明了这些作用的一些分子机制。通过使用新的体内 DLBCL 扩散动物模型,我们在此证明 HGAL 可减少淋巴瘤的扩散并延长生存时间。此外,通过使用无偏见的蛋白质组学方法,我们证明 HGAL 可能与多种细胞骨架蛋白相互作用,从而暗示其在调节淋巴瘤迁移和扩散方面具有多种作用。具体来说,我们表明 HGAL 与微管蛋白相互作用,并且这种相互作用也可能有助于 HGAL 对细胞迁移的影响。这些发现重现了之前在人类中的观察结果,确立了 HGAL 在体内淋巴瘤扩散中的作用,并解释了 HGAL 表达的淋巴瘤患者生存率提高的原因。